Skip to Main Content

Advertisement

Skip Nav Destination

Phase I Study of High-Dose l-Methylfolate in Combination with Temozolomide and Bevacizumab in Recurrent IDH Wild-Type High-Grade Glioma

Cancer Research Communications (2022) 2 (1): 1–9.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal